Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Grant/Award of 31,667 AUTL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Autolus Therapeutics plc (AUTL) | Grant/Award | 31,667 | n/a |
| Jun 23, 2026 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 5,740 | n/a |
| Jun 3, 2026 | ADC Therapeutics SA (ADCT) | Grant/Award | 45,000 | n/a |
| May 5, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Disposition to Issuer | 90,000 | n/a |
| Feb 2, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 1,697 | n/a |
| Nov 6, 2025 | CARDINAL HEALTH INC (CAH) | Grant/Award | 1,067 | n/a |
| Jun 17, 2025 | ADC Therapeutics SA (ADCT) | Tax Withholding | 12,600 | $45.1K |
| Jun 5, 2025 | ADC Therapeutics SA (ADCT) | Grant/Award | 40,000 | n/a |
| Feb 24, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 90,000 | n/a |
| Nov 7, 2024 | CARDINAL HEALTH INC (CAH) | Grant/Award | 1,730 | n/a |